Literature DB >> 12711062

Determining hepatitis C genotype by analyzing the sequence of the NS5b region.

K Sandres-Sauné1, P Deny, C Pasquier, V Thibaut, G Duverlie, J Izopet.   

Abstract

Assays to determine the hepatitis C virus (HCV) genotype have recently become useful for clinical decision making and may be suitable for epidemiological investigations, such as identifying HCV outbreaks in a given population. Molecular assays are the most common diagnostic tools for HCV genotyping. This study compares two genome typing assays, one, the Trugene 5'NC genotyping kit, uses the sequence of the 5' non-coding (5'NC) region and the other, a non-commercial assay, uses the non-structural 5b (NS5b) region. Serum samples from 203 chronically HCV-infected patients were tested. The 5'NC and the NS5b assays were both very effective in identifying the genotype (99 and 98.5%) and the results with the two methods were always concordant for the genotype. The NS5b analysis permitted the identification of the subtype in all samples, whereas the 5'NC region assay did not in 33% of samples. The NS5b analysis showed that one patient had a mixed infection with HCV subtypes 1a and 2c, while the 5'NC assay did not. It is concluded that phylogenetic analysis using both the 5'NC and the NS5b regions are reliable and convenient methods for HCV typing in clinical practice. But analysis of the NS5b region may be more useful for tracing the source of an HCV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711062     DOI: 10.1016/s0166-0934(03)00070-3

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  52 in total

1.  Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus.

Authors:  Suwanna Noppornpanth; Truong Xuan Lien; Yong Poovorawan; Saskia L Smits; Albert D M E Osterhaus; Bart L Haagmans
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  PCR-based in vitro synthesis of hepatitis C virus NS3 protease for rapid phenotypic resistance testing of protease inhibitors.

Authors:  Jinjuan Qiao; Junping Yu; Hang Yang; Hongping Wei
Journal:  J Clin Microbiol       Date:  2014-01-22       Impact factor: 5.948

3.  Ultradeep pyrosequencing of NS3 to predict response to triple therapy with protease inhibitors in previously treated chronic hepatitis C patients.

Authors:  Sylvie Larrat; Om Kulkarni; Jean-Baptiste Claude; Réjane Beugnot; Michaël G B Blum; Katia Fusillier; Julien Lupo; Pauline Tremeaux; Agnès Plages; Alice Marlu; Hervé Duborjal; Anne Signori-Schmuck; Olivier Francois; Jean-Pierre Zarski; Patrice Morand; Vincent Leroy
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

4.  Viral metagenomics applied to blood donors and recipients at high risk for blood-borne infections.

Authors:  Virginie Sauvage; Syria Laperche; Justine Cheval; Erika Muth; Myriam Dubois; Laure Boizeau; Charles Hébert; François Lionnet; Jean-Jacques Lefrère; Marc Eloit
Journal:  Blood Transfus       Date:  2016-03-16       Impact factor: 3.443

5.  Multiplex real-time reverse transcription-PCR assay for determination of hepatitis C virus genotypes.

Authors:  Linda Cook; KaWing Sullivan; Elizabeth M Krantz; Arthur Bagabag; Keith R Jerome
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

6.  Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.

Authors:  Michael O Baclig; Veronica F Chan; John Donnie A Ramos; Juliet Gopez-Cervantes; Filipinas F Natividad
Journal:  Int J Mol Epidemiol Genet       Date:  2010-07-07

7.  Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions.

Authors:  Elisa Martró; Victoria González; Andrew J Buckton; Verónica Saludes; Gema Fernández; Lurdes Matas; Ramón Planas; Vicenç Ausina
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

8.  Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (LiPA), version 2.0.

Authors:  Sylvie Larrat; Jean-Dominique Poveda; Camille Coudret; Katia Fusillier; Nelly Magnat; Anne Signori-Schmuck; Vincent Thibault; Patrice Morand
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

9.  Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.

Authors:  Ruifeng Yang; Xu Cong; Shaocai Du; Ran Fei; Huiying Rao; Lai Wei
Journal:  J Clin Microbiol       Date:  2014-08-06       Impact factor: 5.948

10.  HCV genotyping using statistical classification approach.

Authors:  Ping Qiu; Xiao-Yan Cai; Wei Ding; Qing Zhang; Ellie D Norris; Jonathan R Greene
Journal:  J Biomed Sci       Date:  2009-07-08       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.